Biofrontera Inc.
SEC CIK 1858685 · BFRI · last insider filing 2026-03-06
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Borer John J III | Director | filed 2021 - 2026 |
| Hoffman Beth J. | Director | filed 2021 - 2026 |
| Luebbert Hermann | Director · Executive Chairman | filed 2021 - 2026 |
| Weber Kevin Daniel | Director | filed 2022 - 2026 |
| Lanckriet Heikki | Director | filed 2023 - 2026 |
| de la Huerta Martinez Maria del Pilar | Director | filed 2025 - 2025 |
| Biofrontera AG | Director | filed 2021 - 2025 |
| Monaco Erica L. | Director · Chief Financial Officer/COO | filed 2021 - 2023 |
| Wedge Loretta M. | Director | filed 2021 - 2022 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Leffler Eugene Frederick | Chief Financial Officer | filed 2022 - 2026 |
| Jones George Patrick | Chief Commercial Officer | filed 2025 - 2026 |
| Gates Erica F. | Senior Director Finance | filed 2021 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.